Fractyl Health, Inc. Common Stock
$0.60
$0.01 (+1.56%)
$0.59Day Range$0.60
Key Statistics
Market Cap
$95.51M
Shares Outstanding
159.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 2, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$0.60
Day High
$0.60
Day Low
$0.59
Volume
1.82M
VWAP
$0.60
Prev Close
$0.59
Transactions
--
Acc. Volume
--
About Fractyl Health, Inc. Common Stock
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384173 employees3 VAN DE GRAAFF DRIVE, BURLINGTON, MA, 01803781-902-8800IPO Feb 2, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001572616
- Composite FIGI
- BBG002Y7NH72
- Share Class FIGI
- BBG002Y7NH81
- Ticker Root
- GUTS
- SIC Code
- 3841
About Fractyl Health, Inc. Common Stock (GUTS) Stock
Fractyl Health, Inc. Common Stock (GUTS) closed the 2026-09-18 session at $0.60, up 1.56% versus the previous close (+0.01). The stock opened at $0.60 and traded between $0.59 and $0.60 during that session. Session trading volume was 1.8M shares. The volume-weighted average price (VWAP) is $0.60.
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases, allowing the company to advance metabolic disease treatment from chronic management towards prevention and reversion of the disease. The Revita DMR System (Revita), its lead product candidate, is based on its insights surrounding the potential role of the gut in obesity.
Fractyl Health, Inc. Common Stock has a market capitalization of $95.5 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. GUTS is listed on the XNAS exchange. The company employs approximately 73 people. Fractyl Health, Inc. Common Stock is headquartered in BURLINGTON, MA. The recorded listing date is 2024-02-02.
On this page you can find market GUTS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.